We have correlated the serum levels of TNF alpha and soluble TNF receptor s
uperfamily members with clinico-pathologic parameters in patients of Hodgki
n's disease (HD, N = 26) and non-Hodgkin's lymphoma (NHLs, N = 35), HD pati
ents had significantly higher levels of TNF alpha, sTNFRI, and sTNFRII in s
erum while NHL patients had significantly higher levels of sTNFRI, sTNFRII,
sCD27, and sFas as compared to controls. in NHL patients the levels of sCD
27 correlated directly and significantly with the high-stage disease, bone
marrow involvement, lymph nodal presentation, and serum LDH levels. Similar
ly in NHL patients, levels of sFas also correlated directly and significant
ly with the presence of high stage disease. HD patients with B symptoms had
significantly higher levels of sTNFRII. (C) 2000 Wiley-Liss, Inc.